Stable growth is the basis of PROMOMED's financial policy: Kira Zaslavskaya spoke at the investment forum "Russia is Calling!"

Kira Zaslavskaya, Director of New Products at PROMOMED, took part in the plenary session of the VTB Investment Forum "Russia is Calling!" in St. Petersburg. The event focused on key issues of macroeconomics, risk analysis for capital markets, and the search for promising opportunities for investors in 2026. The theme of the session is "2026: new challenges or transition to sustainable development."

In her speech, Kira Zaslavskaya shared her vision of the role of the Russian capital market in the development of the pharmaceutical industry. She noted the importance of diversifying tools to build long-term relationships with investors.: "The Russian capital market allows us to diversify our approaches without focusing on a single instrument. Credit programs, including concessional lending, and capital raising create a reliable platform for building strong cooperation with partners. We are confident that the stock market will become an even more valuable tool for implementing strategic projects as soon as the key interest rate is lowered."

The report paid special attention to the financial policy of the Company. Kira Zaslavskaya confirmed her commitment to the principles of stability and fulfillment of obligations to investors. She noted that the Company has historically allocated about 10% of its revenue to investment projects, while forming a basic portfolio that serves as a "safety cushion."